Year None202320222021202020192018201720162015201420132012 Feb 21 2023 Clearside Biomedical Announces Positive Data Presentations on CLS-AX OASIS Clinical Trial and Use of SCS Microinjector® Presented at the Angiogenesis and Macula Society Annual Meetings Feb 7 2023 Clearside Biomedical OASIS Data to be Presented at Multiple Upcoming Medical Meetings in February 2023 Feb 6 2023 Clearside Biomedical Announces Leadership Team Update Feb 2 2023 Clearside Biomedical Announces Positive 6-Month Results from OASIS Extension Study with Suprachoroidal CLS-AX (axitinib injectable suspension) in Wet AMD First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4
Feb 21 2023 Clearside Biomedical Announces Positive Data Presentations on CLS-AX OASIS Clinical Trial and Use of SCS Microinjector® Presented at the Angiogenesis and Macula Society Annual Meetings
Feb 7 2023 Clearside Biomedical OASIS Data to be Presented at Multiple Upcoming Medical Meetings in February 2023
Feb 2 2023 Clearside Biomedical Announces Positive 6-Month Results from OASIS Extension Study with Suprachoroidal CLS-AX (axitinib injectable suspension) in Wet AMD
